Initial Statement of Beneficial Ownership (3)
22 Februar 2023 - 11:03PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Pickert Curtis |
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/13/2023
|
3. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [MD]
|
|
(Last)
(First)
(Middle)
1301 CONCORD TERRACE |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
EVP, Chief Operating Officer / |
|
(Street)
SUNRISE, FL 33323
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4) | 2. Amount of Securities Beneficially Owned
(Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) | 4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Common Stock | 29246 (1) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4) | 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) | 6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Explanation of Responses: |
| (1) | Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan. 8,284 shares vest on March 1, 2023, 1,542 shares vest on June 1, 2023, 8,167 shares vest on March 1, 2024, 3,083 shares vest on June 1, 2024 and 8,170 shares vest on March 1, 2025. |
Remarks:
See Exhibit 24.1 - Power of Attorney |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Pickert Curtis
1301 CONCORD TERRACE
SUNRISE, FL 33323 |
|
| EVP, Chief Operating Officer |
|
Signatures
|
| /s/ Mary Ann E. Moore, Attorney-in-Fact | | 2/22/2023 |
| **Signature of Reporting Person | Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
